Andrew Sledziewski
CEO
Biochemistry
Metheor Therapeutics Corp
United States of America
Biography
Dr. Sledziewski (CEO) brings more than 25 years of experience managing biotechnology research organizations. He has spent the last ten years with Epigenomics, an international DNA methylation company, managing its research and IP.
Research Interest
Biochemistry